US Patent 7772182 Stable suspension formulations of erythropoietin receptor agonists
Patent 7772182 was granted and assigned to ALZA on August, 2010 by the United States Patent and Trademark Office.
All edits
Edits on 21 Aug, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 31 Oct, 2023
Golden AI
Edits made to:
Article (+244 characters)
Article
Patent abstract
A suspension formulation for therapeutic use includes a non-aqueous, single-phase vehicle exhibiting viscous fluid characteristics and a particle formulation comprising an erythropoietin receptor agonist dispersed in the vehicle.
Edits on 18 Sep, 2023
Golden AI
Edits made to:
Infobox (+4 properties)
Infobox
Patent Inventor Names
Beth L. Hill0
Kui Liu0
Michael A. Desjardin0
Zengji Li0
Edits on 20 May, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 07772182 Stable suspension formulations of erythropoietin receptor agonists US Patent 7772182 Stable suspension formulations of erythropoietin receptor agonists
Infobox
Patent Number
07772182
Patent Number
7772182
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 3 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 5 Dec, 2021
Golden AI
Edits made to:
Infobox (+8 properties)
US Patent 07772182 Stable suspension formulations of erythropoietin receptor agonists
Infobox
Is a
Current assignee
Patent jurisdiction
Patent number
07772182
Date of patent
August 10, 2010
Patent application number
11194850
Date Filed
August 1, 2005
Patent primary examiner
Find more entities like US Patent 7772182 Stable suspension formulations of erythropoietin receptor agonists
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.